Overview
- The La Jolla Institute for Immunology team published a Cell Reports Medicine paper showing they mapped human CD4+ T cell epitopes for measles and, for the first time, for Nipah virus.
- The study found conserved T cell epitope regions (CTERs) shared by measles and Nipah, including a specific conserved site on the viral fusion (F) protein that attracts many cross-reactive T cells.
- Blood from 31 donors vaccinated with MMR but never exposed to Nipah showed measles-primed CD4+ T cells that could recognize Nipah antigens, demonstrating cross-reactive recognition in human samples.
- Authors propose using CTER-focused immunogen design to broaden paramyxovirus vaccines and note the idea that measles vaccination might offer some benefit in Nipah outbreaks but warn this has not been tested for clinical protection.
- The work is an early mechanistic advance supported by NIAID and CEPI, and the authors stress limits including small sample size and the need for animal studies and clinical trials to show real-world effectiveness.